PDGFB and central nervous system cancer: CSF1R inhibition was shown to be effective in targeting TAMs and prolonging survival in a PDGFB-driven adult glioma mouse model (54); however, in contrast to elimination of about 95% of microglia in naive mice (118), tumor-infiltrating myeloid cell numbers were not affected, but rather their expression signature was changed.